Cytokines in response to proteins predicted in genomic regions of difference of Mycobacterium tuberculosis

Microbiology and Immunology

Volumn 55, Issue 4, 2011, Pages 267-278

  Mustafa, Abu Salim ^a   Al Saidi, Fatmah ^b   El Shamy, Abdel Salam Mahmoud ^b   Al Attiyah, Rajaa ^a  

^a KUWAIT UNIVERSITY   (Kuwait)

^b MINISTRY OF HEALTH   (Kuwait)

Author keywords

Cytokines; RD peptides; Tuberculosis

Indexed keywords

BCG VACCINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 8; LYMPHOTOXIN; MYCOBACTERIUM ANTIGEN; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BACTERIAL STRAIN; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOKINE RESPONSE; GENETIC DIFFERENCE; HUMAN; HUMAN CELL; LUNG TUBERCULOSIS; MYCOBACTERIUM BOVIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; SUPERNATANT; TH1 CELL; TH2 CELL;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; CELLS, CULTURED; CYTOKINES; FEMALE; GENOMICS; HUMANS; IMMUNITY, CELLULAR; MALE; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; TH1 CELLS; TH2 CELLS; TUBERCULOSIS;

MYCOBACTERIUM BOVIS; MYCOBACTERIUM BOVIS BCG; MYCOBACTERIUM TUBERCULOSIS;

EID: 79953093856     PISSN: 03855600     EISSN: 13480421     Source Type: Journal    
DOI: 10.1111/j.1348-0421.2011.00307.x     Document Type: Article

References (60)

1. Dye C., Bassili A., Bierrenbach A.L., Broekmans J.F., Chadha V.K., Glaziou P., Gopi P.G., Hosseini M., Kim S.J., Manissero D., Onozaki I., Rider H.L., Scheele S., van Leth F., Van Der Werf M., Williams B.G. (2008) Measuring tuberculosis burden, trends, and the impact of control programmes. Lancet Infect Dis 8: 233-43.
2. Flynn J. (2004) Immunology of tuberculosis and implications in vaccine development. Tuberculosis 4: 93-101.
3. Mustafa A.S. (2009) Vaccine potential of Mycobacterium tuberculosis-specific genomic regions: in vitro studies in humans. Expert Rev Vaccines 8: 1309-12.
4. Aagaard C., Hoang T.T., Izzo A., Billeskov R., Troudt J., Arnett K., Keyser A., Elvang T., Andersen P., Dietrich J. (2009) Protection and polyfunctional T cells induced by Ag85B-TB10.4/IC31 against Mycobacterium tuberculosis is highly dependent on the antigen dose. PLoS One 4: e5930.
5. Al-Attiyah R., Mustafa A.S., Abal A.T., Madi N.M., Andersen P. (2003) Restoration of mycobacterial antigen-induced proliferation and interferon-gamma responses in peripheral blood mononuclear cells of tuberculosis patients upon effective chemotherapy. FEMS Immunol Med Microbiol 38: 249-56.
6. Al-Attiyah R., Madi N., El-Shamy A.S., Herald W., Andersen P., Mustafa A.S. (2006) Cytokine profiles in tuberculosis patients and healthy subjects in response to complex and single antigens of Mycobacterium tuberculosis. FEMS Immunol Med Microbiol 47: 254-61.
7. Al-Attiyah R., El-Shazly A., Mustafa A.S. (2006) Assessment of in vitro immunity to Mycobacterium tuberculosis in a human peripheral blood infection model using a luciferase reporter construct of M. tuberculosis H37Rv. Clin Exp Immunol 145: 520-7.
8. Reed S.G., Coler R.N., Dalemans W., Tan E.V., DeLa Cruz E.C., Basaraba R.J., Orme I.M., Skeiky Y.A., Alderson M.R., Cowgill K.D., Prieels J.P., Abalos R.M., Dubois M.C., Cohen J., Mettens P., Lobet Y. (2009) Defined tuberculosis vaccine, Mtb72F/AS02A, evidence of protection in cynomolgus monkeys. Proc Natl Acad Sci USA 106: 2301-6.
9. Roach D.R., Briscoe H., Saunders B., France M.P., Riminton S., Britton W.J. (2001) Secreted lymphotoxin-alpha is essential for the control of an intracellular bacterial infection. J Exp Med 193: 239-46.
10. Ates O., Musellim B., Ongen G., Topal-Sarikaya A. (2008) Interleukin-10 and tumor necrosis factor-alpha gene polymorphisms in tuberculosis. J Clin Immunol 28: 232-6.
11. Bai X., Wilson S E., Chmura K., Feldman N.E., Chan E.D. (2004) Morphometric analysis of Th(1) and Th(2) cytokine expression in human pulmonary tuberculosis. Tuberculosis 84: 375-85.
12. Harris J., De Haro S.A., Master S.S., Keane J., Roberts E.A., Delgado M., Deretic V. (2007) T helper 2 cytokines inhibit autophagic control of intracellular Mycobacterium tuberculosis. Immunity 27: 505-17.
13. Sai Priya V.H., Anuradha B., Latha Gaddam S., Hasnain S.E., Murthy K.J., Valluri V.L. (2009) In vitro levels of interleukin 10 (IL-10) and IL-12 in response to a recombinant 32-kilodalton antigen of Mycobacterium bovis BCG after treatment for tuberculosis. Clin Vaccine Immunol 16: 111-5.
14. Turner J., Gonzalez-Juarrero M., Ellis D.L., Basarba R.J., Kipnis A., Orme I.M., Cooper A.M. (2002) In vivo IL-10 production reactivates chronic pulmonary tuberculosis in C57BL/6 mice. J Immunol 169: 6343-51.
15. Ehlers S. (1999) Immunity to tuberculosis: a delicate balance between protection and pathology. FEMS Immunol Med Microbiol 23: 149-58.
16. Behr M.A., Wilson M.A., Gill W.P., Salamon H., Schoolnik G.K., Rane S., Small P.M. (1999) Comparative genomics of BCG vaccines by whole-genome DNA microarray. Science 284: 1520-3.
17. Mustafa A.S. (2005) Recombinant and synthetic peptides to identify Mycobacterium tuberculosis antigens and epitopes of diagnostic and vaccine relevance. Tuberculosis (Edinb) 85: 367-76.
18. Mustafa A.S. (2005) Mycobacterial gene cloning and expression, comparative genomics, bioinformatics and proteomics in relation to the development of new vaccines and diagnostic reagents. Med Princ Pract 14(Suppl 1): 27-34.
19. Goletti D., Stefania C., Butera O., Amicosante M., Ernst M., Sauzullo I., Vullo V., Cirillo D., Borroni E., Markova R., Drenska R., Dominguez J., Latorre I., Angeletti C., Navarra A., Petrosillo N., Lauria F.N., Ippolito G., Migliori G.B., Lange C., Girardi E. (2008) Accuracy of immunodiagnostic tests for active tuberculosis using single and combined results: a multicenter TBNET-Study. PLoS One 3: e3417.
20. Mustafa A.S., Al-Attiyah R. (2009) Identification of Mycobacterium tuberculosis-specific genomic regions encoding antigens inducing protective cellular immune responses. Indian J Exp Biol 47: 498-504.
21. Chen J., Su X., Zhang Y., Wang S., Shao L., Wu J., Wang F., Zhang S., Wang J., Weng X., Wang H., Zhang W. (2009) Novel recombinant RD2- and RD11-encoded Mycobacterium tuberculosis antigens are potential candidates for diagnosis of tuberculosis infections in BCG-vaccinated individuals. Microbes Infect 11: 876-85.
22. Mustafa A.S. (2001) Biotechnology in the development of new vaccines and diagnostic reagents against tuberculosis. Curr Pharm Biotechnol 2: 157-73.
23. Mustafa A.S. (2002) Development of new vaccines and diagnostic reagents against tuberculosis. Mol Immunol 39: 113-9.
24. Ganguly N., Siddiqui I., Sharma P. (2008) Role of M. tuberculosis RD-1 region encoded secretory proteins in protective response and virulence. Tuberculosis (Edinb) 88: 510-7.
25. Mustafa A.S., El-Shamy A.M., Madi N.M., Amoudy H.A., Al-Attiyah R. (2008) Cell-mediated immune responses to complex and single mycobacterial antigens in tuberculosis patients with diabetes. Med Princ Pract 17: 325-30.
26. Mustafa A.S. (2009) Th1-cell reactivity and HLA-DR binding prediction for promiscuous recognition of MPT63 (Rv1926c), a major secreted protein of Mycobacterium tuberculosis. Scand J Immunol 69: 213-22.
27. Al-Attiyah R., Mustafa A.S. (2008) Characterization of human cellular immune responses to novel Mycobacterium tuberculosis antigens encoded by genomic regions absent in Mycobacterium bovis BCG. Infect Immun 76: 4190-8.
28. Hanif S.N.M., El-Shamy A.M., Al-Attiyah R., Mustafa A.S. (2008) Whole blood assays to identify Th1 cell antigens and peptides encoded by Mycobacterium tuberculosis-specific RD1 genes. Med Princ Pract 17: 244-9.
29. Mustafa A.S., Al-Attiyah R., Hanif S.N.M., Shaban F.A. (2008) Efficient testing of large pools of Mycobacterium tuberculosis RD1 peptides and identification of major antigens and immunodominant peptides recognized by human Th1 cells. Clin Vaccine Immunol 15: 916-24.
30. Mustafa A.S., Abal A.T., Shaban F., El-Shamy A.M., Amoudy H.A. (2005) HLA-DR binding prediction and experimental evaluation of mycolyl transferase (Ag85B), a major secreted antigen of Mycobacterium tuberculosis. Med Princ Pract 14: 140-6.
31. Mustafa A.S., Amoudy H.A., Wiker H.G., Abal A.T., Ravn P., Oftung F., Andersen P. (1998) Comparison of antigen-specific T-cell responses of tuberculosis patients using complex or single antigens of Mycobacterium tuberculosis. Scand J Immunol 48: 535-43.
32. Mustafa A.S., Shaban F.A., Al-Attiyah R., Abal A.T., El-Shamy A.M., Andersen P., Oftung F. (2003) Human Th1 cell lines recognize the Mycobacterium tuberculosis ESAT-6 antigen and its peptides in association with frequently expressed HLA class II molecules. Scand J Immunol 57: 125-34.
33. Mustafa A.S. (2009) HLA-promiscuous Th1-cell reactivity of MPT64 (Rv1980c), a major secreted antigen of Mycobacterium tuberculosis, in healthy subjects. Med Princ Pract 18: 385-92.
34. Mustafa A.S., Shaban F.A. (2006) ProPred analysis and experimental evaluation of promiscuous Th1 cell epitopes of three major secreted antigens of Mycobacterium tuberculosis. Tuberculosis (Edinb) 86: 115-24.
35. Mustafa A.S., Shaban F.A., Abal A.T., Al-Attiyah R., Wiker H.G., Lundin K.E., Oftung F., Huygen K. (2000) Identification and HLA restriction of naturally derived Th1-cell epitopes from the secreted Mycobacterium tuberculosis antigen 85B recognized by antigen-specific human CD4+ T cell lines. Infect Immun 68: 3933-40.
36. Mustafa A.S., Skeiky Y.A., Al-Attiyah R., Alderson M.R., Hewinson R.G., Vordermeier H.M. (2006) Immunogenicity of Mycobacterium tuberculosis antigens in Mycobacterium bovis BCG-vaccinated and M. bovis-infected cattle. Infect Immun 74: 4566-72.
37. Al-Attiyah R., Mustafa A.S. (2004) Computer-assisted prediction of HLA-DR binding and experimental analysis for human promiscuous Th1-cell peptides in the 24 kDa secreted lipoprotein (LppX) of Mycobacterium tuberculosis. Scand J Immunol 59: 16-24.
38. Al-Attiyah R., Mustafa A.S., Abal A.T., El-Shamy A.M., Dalemans W., Skeiky Y.A.W. (2004) In vitro cellular immune responses to complex and newly defined recombinant antigens of Mycobacterium tuberculosis. Clin Exp Immunol 138: 139-44.
39. Mustafa A.S., Cockle P.J., Shaban F., Hewinson R.G., Vordermeier H.M. (2002) Immunogenicity of Mycobacterium tuberculosis RD1 region gene products in infected cattle. Clin Exp Immunol 130: 37-42.
40. Munk M.E., Emoto M. (1995) Functions of T-cell subsets and cytokines in mycobacterial infections. Eur Respir J 20: 668s-75s.
41. Schauf V., Rom W.N., Smith K.A., Sampaio E.P., Meyn P.A., Tramontana J.M., Cohn Z.A., Kaplan G. (1993) Cytokine gene activation and modified responsiveness to interleukin-2 in the blood of tuberculosis patients. J Infect Dis 168: 1056-9.
42. Nakaya M., Yoneda T., Yoshikawa M; Tsukaguchi K., Tokuyama T., Fu A., Okamoto Y., Fukuoka K., Yamamoto C., Fukuoka A. (1995) The evaluation of interleukin-8 (IL-8) and tumor necrosis factor-alpha (TNF-alpha) level in peripheral blood of patients with active pulmonary tuberculosis. Kekkaku 70: 461-6.
43. Jo E.L., Park J.K., Dockrell H.M. (2003) Dynamics of cytokine generation in patients with active pulmonary tuberculosis. Curr Opin Infect Dis 16: 205-10.
44. Wang C.H., Lin H.C., Liu C.Y. (2001) Upregulation of inducible nitric oxide synthase and cytokine secretion in peripheral blood monocytes from pulmonary tuberculosis patients. Int J Tuberc Lung Dis 5: 283-91
45. Sadek M.I., Sada E., Toossi Z., Schwander S.K., Rich E.A. (1998) Chemokines induced by infection of mononuclear phagocytes with mycobacteria and present in lung alveoli during active pulmonary tuberculosis. Am J Respir Cell Mol Biol 19: 513-21.
46. Algood H.M.S., Lin P.L., Flynn J.L. (2005) Tumor necrosis factor and chemokine interactions in the formation and maintenance of granulomas in tuberculosis. Clin Infect Dis 41(Suppl 3): S189-93.
47. Somoskovi A., Zissel G., Zipfel P.F., Ziegenhagen M.W., Klaucke J., Haas H., Schlaak M., Muller-Quernheim J. (1999) Different cytokine patterns correlate with the extension of disease in pulmonary tuberculosis. Eur Cytokine Netw 10: 135-42.
48. Rey A.D., Mahuad C.V., Bozza V.V., Bogue C., Farroni M.A., Bay M.L., Bottasso O.A., Besedovsky H.O. (2007) Endocrine and cytokine responses in humans with pulmonary tuberculosis. Brain Behav Immun 21: 171-9.
49. Marchant A., Amedei A., Azzurri A., Vekemans J., Benagiano M., Benagiano J., Tamburini C., Lienhardt C., Corrah T., McAdam K.P., Romagnani S., D'Elios M.M., Del Prete G. (2001) Polarization of PPD-specific T-cell response of patients with tuberculosis from Th0 to Th1 profile after successful antimycobacterial therapy or in vitro conditioning with interferon-alpha or interleukin-12. Am J Respir Cell Mol Biol 24: 187-94.
50. Stadler B.M., Dougherty S.F., Farrar J.J., Oppenheim J.J. (1981) Relationship of cell cycle to recovery of IL-2 activity from human mononuclear cells, human and mouse T cell lines. J Immunol 127: 1936-40.
51. Tsunoda T., Tanimura H., Yamaue H., Iwahashi M., Tani M., Noguchi K., Hotta T., Mizobata S., Arii K. (1996) Clonal and functional analysis for the augmentation of tumour-infiltrating lymphocytes by interleukin 4. Br J Cancer 74: 1085-9.
52. Biselli R., Mariotti S., Sargentini V., Sauzullo I., Lastilla M., Mengoni F., Vanini V., Girardi E., Goletti D., D' Amelio R., Nisini R. (2010) Detection of interleukin-2 in addition to interferon-gamma discriminates active tuberculosis patients, latently infected individuals, and controls. Clin Microbiol Infect 16: 1282-4.
53. Morosini M., Meloni F., Uccelli M., Marone Bianco A., Solari N., Fietta A.M. (2005) Ex vivo evaluation of PPD-specific IFN-gamma or IL-5 secreting cells in the peripheral blood and lungs of patients with tuberculosis. Int J Tuberc Lung Dis 9: 753-59.
54. van Crevel R., Ottenhoff T.H.M., van der Meer J.W.M. (2002) Innate immunity to Mycobacterium tuberculosis. Clin Microbiol Rev 15: 294-309.
55. Murray P.J., Wang L., Onufryk C., Tepper R.I., Young R.A. (1997) T cell-derived IL-10 antagonizes macrophage function in mycobacterial infection. J Immunol 158: 315-21.
56. Jacobs M., Brown N., Allie N., Gulert R., Ryffel B. (2000) Increased resistance to mycobacterial infection in the absence of interleukin-10. Immunology 100: 494-501.
57. Mustafa Abu S., Al-Attiyah R. (2003) Tuberculosis: looking beyond BCG vaccines. J Postgrad Med 49: 134-40.
58. Wiker H.G., Mustafa T., Målen H., Riise A.M. (2006) Vaccine approaches to prevent tuberculosis. Scand J Immunol 64: 243-50.
59. Mustafa A.S., Al-Attiyah R. (2004) Mycobacterium tuberculosis antigens and peptides as new vaccine candidates and immunodiagnostic reagents against tuberculosis. Kuwait Med J 36: 171-6.
60. Zhang H., Shi C.H., Xue Y., Bai Y.L., Wang L.M., Xu Z.K. (2006) Immune response and protective efficacy induced by fusion protein ESAT6-CFP10 of M. tuberculosis in mice. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi 22: 443-6.